Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04069013 · ClinicalTrials.gov registry record · NA

Standard vs Mini-PCNL for the Treatment of Stone Disease

A NA study of Kidney Diseases and Kidney Stone, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04069013 is a NA study of Kidney Diseases and Kidney Stone that has completed, run by The Cleveland Clinic. The registered enrollment target is 18 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04069013, a NA study of Kidney Diseases and Kidney Stone, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.

Interventions

  • PROCEDURE PCNL

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-05-01
Est. Completion 2025-11-11
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04069013

The ClinicalTrials.gov registry entry for NCT04069013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which PCNL is the first listed.

NCT04069013 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04069013 about?

NCT04069013 is a clinical study titled "Standard vs Mini-PCNL for the Treatment of Stone Disease". Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.

What is the current status of trial NCT04069013?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-05-01. Estimated completion is 2025-11-11.

What conditions does trial NCT04069013 study?

This clinical trial studies the following conditions: Kidney Diseases, Kidney Stone, Urolithiasis, Kidney Calculi, Ureteral Calculi.

What interventions are being tested in trial NCT04069013?

The interventions under investigation include: PCNL (PROCEDURE).

Who is sponsoring clinical trial NCT04069013?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04069013 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.